A phase I study to assess the safety and activity of topical lovastatin (FP252S) for the prevention of chemotherapy-induced alopecia

Supportive Care in Cancer

Volumn 15, Issue 9, 2007, Pages 1109-1112

  Joshi, Rohit ^a   Olver, Ian ^a,c   Keefe, Dorothy ^a   Marafioti, Toni ^a   Smith, Keith ^b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b Cancer Council Australia ^*  (Australia)

^c CANCER COUNCIL AUSTRALIA   (Australia)

Author keywords

Alopecia; Chemotherapy; Lovastatin

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; MEVINOLIN; PACLITAXEL;

ALOPECIA; ARTICLE; BREAST CANCER; BURNING SENSATION; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ACTIVITY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MULTIPLE CYCLE TREATMENT; OVARY CANCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SCALP PRURITUS;

ADMINISTRATION, TOPICAL; ALOPECIA; ANTINEOPLASTIC AGENTS; DERMATOLOGIC AGENTS; DOXORUBICIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; TAXOIDS; TREATMENT OUTCOME;

EID: 34548337131     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0267-2     Document Type: Article

References (18)

1. Benjamin B, Ziginskas D, Harman J, Meakin T (2002) Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: a pilot study. Psychooncology 11:244-248
2. Crounse RG, Van Scott EJ (1960) Changes in scalp hair roots as a measure of toxicity from cancer chemotherapeutic drugs. J Invest Dermatol 35:83-90
3. Dean JC, Salmon SE, Griffiths KS (1997) Prevention of doxorubicin-induced hair loss with scalp hypothermia. N Engl J Med 301:1427-1429
4. DeSpain JD (1992) Dermatologic toxicity of chemotherapy. Semin Oncol 19:501-507
5. Fischer D, Knobf M, Durivage H (1997) The cancer chemotherapy handbook. Mosby, St. Louis, MO, pp 514-526
6. Duvic M, Lemak N, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, Trancik RJ, Bandstra BA, Compton LD (1996) A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol 35:74-78
7. Hood AF (1996) Dermatologic toxicity. In: Perry MC (ed) The chemotherapy source book, 2nd edn. Williams & Wilkins, Baltimore, pp 595-606
8. Jakobisiak M, Bruno S, Skierski JS, Darzynkiewicz Z (1991) Cell cycle-specific effects of lovastatin. Proc Natl Acad Sci USA 88:3628-3632
9. Keyomarsi K, Sandoval L, Band V, Pardee AB (1991) Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res 51:3602-3609
10. Pillans PI, Woods DJ (1995) Drug-associated alopecia. Int J Dermatol 34:149-158
11. Ron IG, Kalmus Y, Kalmus Z, Inbar M, Chaitchik S (1997) Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy. Support Care Cancer 5:136-138
12. Rodriguez R, Machiavelli M, Leone B, Romero A, Cuevas MA, Langhi M, Romero Acuna L, Romero Acuna J, Amato S, Barbieri M et al (1994) Minoxidil (Mx) as a prophylaxis of doxorubicin-induced alopecia. Ann Oncol 5(8):769-770
13. Macduff C, Mackenzie T, Hutcheon A, Melville L, Archibald H (2003) The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. Eur J Cancer Care (Engl) 12(2):154-161
14. Grevelman EG, Breed WP (2005) Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol 16(3):352-358
15. Ridderheim M, Bjurberg M, Gustavsson A (2003) Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer 11(6):371-377
16. Meijer L, Knockaert M, Damiens E (2001) Prevention of chemotherapy-induced alopecia by cyclin-dependant kinase inhibitors. Bull Cancer 88(4):347-350
17. Sredni B, Albeck M, Tichler T, Shani A, Shapira J, Bruderman I, Catane R, Kaufman B, Kalechman Y (1995) Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide. J Clin Oncol 13(9):2342-2353
18. Wang J, Lu Z, Au JL (2006) Protection against chemotherapy-induced alopecia. Pharm Res 23(11):2505-2514